2nd Quarter - Report

PRIME THERAPEUTICS for PRIME THERAPEUTICS

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.1895: The Lower Health Care Costs Act, Sec. 306, Health Plan Oversight of PBMs. CURES 2.0: provisions related to value-based care. HR 19/S.3129: The Lower Costs, More Cures Act, reforms drug pricing by promoting greater competition and redesign of the Medicare Part D benefit. HR 3: Elijah E. Cummings Lower Drugs Cost Now Act, provisions to modernize the Part D benefit and provisions that require HHS to negotiate prices for certain drugs. Issues related to the drug supply chain country of origin and impact on the availability of drugs in the USA.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1895 (116th), H.R. 3 (116th), H.R. 19 (116th), S. 3129 (116th)

Medicare/Medicaid MMM

HR 3: Elijah E. Cummings Lower Drugs Cost Now Act,-provisions to modernize the Part D benefit and provisions that require HHS to negotiate prices for certain drugs. HR 19/S 3129: The Lower Costs, More Cures Act, reforms drug pricing by promoting greater competition and redesign of the Medicare Part D benefit. HR 6739: Ensuring Seniors Access to COVID Treatments Act. HR 6800: HEROES Act, Sec. 30205 Requiring Coverage Under Medicare PDPS and MA-PD Plans, Without the Imposition of Cost Sharing or Utilization Management Requirements, of Drugs Intended to Treat Covid - During Certain Emergencies. Value-based contracting and Medicaid Best Price. Sec. 3714 of P.L. 116-136 The CARES Act, related to requiring that Medicare Part D and C plan beneficiaries have access to 90-day prescriptions at the beneficiarys request. S. 2543: The Prescription Drug Pricing Reduction Act (PDPRA) of 2019 -provisions on Medicare Part D and PBMs. Outreach on pharmacy direct and indirect remuneration in Medicare Part D and real time benefit tools. Implementation of Sec. 2003 SUPPORT for Patients and Communities Act, provisions related to implementation of Every Prescription Conveyed Securely Act.

LobbyistCovered position, as disclosed
JULIE CAROL CANTOR-WEINBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 3 (116th), H.R. 6739 (116th), H.R. 19 (116th), H.R. 6800 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.